Insider · CIK 0001562229
Patrick F. Williams
Files at BRTX (BioRestorative Therapies, Inc.), NPCE (NeuroPace Inc). First filing -, latest -.
Patrick F. Williams files SEC Form 4 as director and CFO at BRTX (BioRestorative Therapies, Inc.), and also at NPCE (NeuroPace Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Patrick F. Williams has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 20, 2026 | NPCE NeuroPace Inc | FTax withholding Common Stock | -1,162 | $14.28 | $17k | 67,508 | 22 d ago |
| Jun 20, 2025 | NPCE NeuroPace Inc | AGrant or award Common Stock | +51,850 | $0.00 | $0 | 51,850 | Jun 24, 2025 |
| Jun 20, 2025 | NPCE NeuroPace Inc | AGrant or award Stock Option (Right to Buy)derivative | +87,950 | $0.00 | $0 | 87,950 | Jun 24, 2025 |
| Feb 14, 2025 | BRTX BioRestorative Therapies, Inc. | AGrant or award Stock Optionderivative | +52,632 | $0.00 | $0 | 52,632 | Feb 19, 2025 |
Questions about Patrick F. Williams
Answered from the filings on this page, as of the latest one.
Is Patrick F. Williams buying or selling?
Patrick F. Williams has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Patrick F. Williams's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrick F. Williams has 0.
Where does Patrick F. Williams file Form 4?
Patrick F. Williams has filed Form 4 at BRTX (BioRestorative Therapies, Inc.); NPCE (NeuroPace Inc) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.